Jeff Yass’s Gain Therapeutics GANX Stock Holding History

Jeff Yass's GANX Position: Q2 2026 in Review

Jeff Yass reduced its Gain Therapeutics (GANX) stake by 82% in Q2 2026, selling an estimated $651K and leaving 78,206 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #12157.

Jeff Yass first reported a position in GANX in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.2M in Q4 2025. 50 funds tracked by Wall St. Rank hold GANX as of Q2 2026.

• Jeff Yass held 78,206 shares of Gain Therapeutics worth $159K as of Q2 2026.
• Jeff Yass sold 353,061 Gain Therapeutics shares in Q2 2026, an estimated $651K.
• Gain Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12157 holding.
• Jeff Yass first reported a position in Gain Therapeutics in Q4 2021 and has held it in 13 quarters since.
• Jeff Yass's Gain Therapeutics position peaked at $2.2M in Q4 2025.
• 50 funds tracked by Wall St. Rank held Gain Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.